SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

26 Jun 2008 12:23

RNS Number : 6132X
Rentokil Initial PLC
26 June 2008
Ā 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by anĀ issuerĀ to make aĀ RISĀ notification required byĀ DRĀ 3.1.4R(1).

Ā 

(1)

AnĀ issuerĀ making a notification in respect of a transaction relating to theĀ sharesĀ or debentures of theĀ issuerĀ should completeĀ boxes 1 to 16, 23 and 24.

(2)

AnĀ issuerĀ making a notification in respect of a derivative relatingĀ toĀ theĀ sharesĀ of theĀ issuerĀ should completeĀ boxes 1 to 4, 6, 8,Ā 13, 14, 16, 23 and 24.Ā 

(3)

AnĀ issuerĀ making a notification in respect of options granted to aĀ director/person discharging managerial responsibilitiesĀ should completeĀ boxes 1 to 3Ā and 17 to 24.Ā 

(4)

AnĀ issuerĀ making a notification in respect of aĀ financial instrumentĀ relating to theĀ sharesĀ of theĀ issuerĀ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.Ā 

Ā 

Please complete all relevant boxes in block capital letters.

1.Ā Name of theĀ issuer

Rentokil Initial plc

2.Ā State whether the notification relates to (i) a transaction notified in accordance withĀ DRĀ 3.1.4R(1)(a); or

(ii)Ā DRĀ 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; orĀ 

(iii) both (i) and (ii)

Pursuant toĀ (i) and (ii) above

3.Ā Name ofĀ person discharging managerial responsibilities/director

Andrew Macfarlane

Henry Chandler

Petar Cvetkovic

Andy Hobart

Andy Kemp

Bryan Kinsella

David Liu

Peter Lloyd

4.Ā State whether notification relates to aĀ personĀ connected with aĀ person discharging managerial responsibilities/directorĀ named in 3 and identify theĀ connected person

Not applicable

5.Ā Indicate whether the notification is in respect of a holding of theĀ personĀ referred to in 3 or 4 above or in respect of a non-beneficial interest

Pursuant to 3. above

6.Ā Description ofĀ sharesĀ (includingĀ class), debentures or derivatives or financial instruments relating toĀ shares

Ordinary shares of 1 pence each

7.Ā Name of registered shareholders(s) and, if more than one, the number ofĀ sharesĀ held by each of them

Not applicable

8.Ā State the nature of the transaction

Awards under theĀ 2006Ā Performance Share PlanĀ - 2008 award

9.Ā Number ofĀ shares, debentures or financial instruments relating toĀ sharesĀ acquired

Not applicable

10.Ā Percentage of issuedĀ classĀ acquired (treasury sharesĀ of thatĀ classĀ should not be taken into account when calculating percentage)

Not applicable

11.Ā Number ofĀ shares, debentures or financial instruments relating toĀ sharesĀ disposed

Not applicable

12.Ā Percentage of issuedĀ classĀ disposed (treasury sharesĀ of thatĀ classĀ should not be taken into account when calculating percentage)Ā 

Not applicable

13.Ā Price perĀ shareĀ or value of transaction

Not applicable

14.Ā Date and place of transaction

Not applicable

15.Ā Total holding following notification and total percentage holding following notification (anyĀ treasury sharesĀ should not be taken into account when calculating percentage)

Not applicable

16.Ā Date issuer informed of transaction

25 June 2008

If aĀ person discharging managerial responsibilitiesĀ has been granted options by theĀ issuerĀ complete the following boxes

17.Ā Date of grant

25Ā June 2008Ā - Performance Share Plan award

18.Ā Period during which or date on which it can be exercised

26Ā JuneĀ 2011Ā toĀ 25Ā June 2018Ā (subject to performance conditions)

19.Ā Total amount paid (if any) for grant of the option

Nil

20.Ā Description ofĀ sharesĀ or debentures involved (classĀ and number)

Ordinary shares of 1 pence each

Andrew MacfarlaneĀ  1,248,000 Performance share plan awards

Henry ChandlerĀ  840,000 Performance share plan awards

Petar CvetkovicĀ  1,120,000 Performance share plan awards

Andy HobartĀ  804,000 Performance share plan awards

Andy KempĀ  710,400 Performance share plan awards

Bryan Kinsella 544,800Ā  Performance share plan awards

David Liu 811,670 Performance share plan awards

Peter Lloyd 506,880 Performance share plan awards

Ā 

21.Ā Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

Nil

22.Ā Total number ofĀ sharesĀ or debentures over which options held following notification

Ā 

a. Andrew Macfarlane 2,001,197Ā  Performance share plan awards

Ā 

b. Henry Chandler 1,332,296Ā  Performance share awards

527,286Ā  Pre 2006 ESOS share options

Ā 

c. Petar Cvetkovic 1,120,000 Performance share plan awards

Ā 

d. Andy Hobart 1,300,763 Performance shareĀ planĀ awards

Ā 

e. Andy Kemp 1,155,914Ā  Performance shareĀ planĀ awards

Ā 

f. Bryan Kinsella 624,438 Performance share plan awards

Ā 

g. David LiuĀ  1,334,676 Performance shareĀ planĀ awards

Ā 

h. Peter Lloyd 1,029,886Ā  Performance share plan awards

166,619Ā  Pre 2006 ESOS share options

23.Ā Any additional information

Not applicable

24.Ā Name of contact and telephone number for queries

Paul Griffiths,Ā Company SecretaryĀ -Ā 020Ā 7592 2700

25.Ā Name and signature of duly authorised officer ofĀ issuerĀ responsible for making notification

Paul Griffiths, Company Secretary

26.Ā Date of notification

26 June 2008

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
RDSBBGDLIBDGGIL
Date   Source Headline
3rd Oct 20222:36 pmRNSBlock listing Interim Review
30th Sep 202211:42 amRNSDirector Declaration
14th Sep 20225:55 pmRNSDirector/PDMR Shareholding
14th Sep 202212:21 pmRNSDirector/PDMR Shareholding
7th Sep 20222:38 pmRNSPublication of Circular-Prospectus & GM Notice
22nd Aug 20227:00 amRNSHolding(s) in Company
5th Aug 20222:02 pmRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNS2022 Interim Results
27th Jul 20229:54 amRNSDirector Declaration
18th Jul 20223:11 pmRNSHolding(s) in Company
15th Jul 20225:30 pmRNSHolding(s) in Company
15th Jul 202211:57 amRNSHolding(s) in Company
27th Jun 20222:27 pmRNSPost stabilisation notice - Rentokil Initial Plc
22nd Jun 20224:16 pmRNSHolding(s) in Company
21st Jun 20223:37 pmRNSDirector/PDMR Shareholding
20th Jun 20229:12 amRNSPre stabilisation notice - Rentokil Initial Plc
20th May 202210:20 amRNSDirector/PDMR Shareholding
12th May 20227:00 amRNSResult of AGM
21st Apr 20227:00 amRNSQ1 Trading Update
1st Apr 20227:00 amRNSBlock listing Interim Review
31st Mar 20226:15 pmRNSTotal Voting Rights
30th Mar 20229:44 amRNSAnnual Financial Report
29th Mar 20222:20 pmRNSDirector/PDMR Shareholding
25th Mar 20224:31 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSUpdate on Terminix acquisition
14th Mar 202211:00 amRNSAdditional Listing
3rd Mar 20227:00 amRNSFinal Results
2nd Mar 202210:29 amRNSDirector/PDMR Shareholding
28th Feb 20224:47 pmRNSHolding(s) in Company
22nd Dec 20215:38 pmRNSDirector/PDMR Shareholding
21st Dec 20214:09 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSFurther re Terminix Acqn S&P reaffirms BBB rating
15th Dec 20212:02 pmRNSDirector/PDMR Shareholding
14th Dec 20217:00 amRNSAcquisition of Terminix by Rentokil Initial plc
22nd Oct 202110:42 amRNSDirector Declaration
21st Oct 20217:00 amRNSQ3 Trading Update
1st Oct 202110:00 amRNSBlock listing Interim Review
28th Sep 20217:00 amRNSNotice of Capital Markets Day
17th Aug 20216:09 pmRNSDirector/PDMR Shareholding
12th Aug 20214:48 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSInterim Results
8th Jul 20217:00 amRNSNotice of termination of guarantee
11th Jun 20211:50 pmRNSNotice of Early Redemption
12th May 20216:03 pmRNSResult of AGM
22nd Apr 20217:00 amRNSQ1 Trading Update
7th Apr 20212:01 pmRNSDirector/PDMR Shareholding
1st Apr 20216:30 pmRNSDirector/PDMR Shareholding
1st Apr 202110:23 amRNSBlock listing Interim Review
1st Apr 202110:16 amRNSChange of Registered Office
31st Mar 20214:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.